You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

250 Results
Guidelines and Advice
Status: Current
ID: GL 17-12
Version: N/A
Sep 2019
Guidelines and Advice
Status: Current
ID: pet 2019-1
Version: N/A
Nov 2019
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative
Drugs Used:
CISplatin,
etoposide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2019
Regimen
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
lenvatinib (Unfunded),
everolimus (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Dec 2019
Guidelines and Advice
Status: Current
Oct 2019
Cancer facts
Nov 2020
Guidelines and Advice
Status: Current
ID: PET 2020-1
Version: N/A
Nov 2020
Cancer facts
Nov 2020
Statistical Reports
*/ For the most recent data, refer to the Ontario Cancer Screening Performance Report 2023. Effective cancer screening through organized...
Nov 2020
Guidelines and Advice
Status: Current
ID: GL 1-14
Version: 3
Oct 2019

Pages